Search clinical trials for: Poly(ADP-ribose) Polymerase Inhibitors
Total 2242 results
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustNot yet recruitingOvarian Cancer RecurrentUnited Kingdom
-
Grupo Español de Tratamiento de Tumores de Cabeza...GlaxoSmithKline; MFARRecruitingHead and Neck Squamous Cell CarcinomaSpain
-
Seoul National University HospitalRecruitingAdvanced Breast CancerKorea, Republic of
-
zr Pharma & GmbHFoundation Medicine; Myriad Genetics, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Spain, Canada, Australia, United Kingdom, France
-
zr Pharma & GmbHCompleted
-
University College, LondonAstraZenecaWithdrawn
-
University Medical Centre LjubljanaRecruiting
-
Gustave Roussy, Cancer Campus, Grand ParisRecruiting
-
Shandong UniversitySun Yat-sen University; Zai Lab (Shanghai) Co., Ltd.; Tongji Hospital; Women's...RecruitingEndometrial Carcinoma | Serous CarcinomaChina
-
National University Hospital, SingaporeRecruiting
-
University of Alabama at BirminghamTesaro, Inc.; Susan G. Komen Breast Cancer Foundation; Translational Breast Cancer... and other collaboratorsRecruitingMetastatic Breast Cancer | HER2 Positive Breast CarcinomaUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
The Netherlands Cancer InstituteActive, not recruitingBreast CancerNetherlands, France
-
AstraZenecaActive, not recruitingUrinary Bladder NeoplasmsUnited States, Spain, Canada, Taiwan, Vietnam, Korea, Republic of, Russian Federation
-
New Mexico Cancer Care AllianceActive, not recruitingPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States
-
Center Trials & TreatmentBioGene PharmaceuticalWithdrawnBreast Neoplasm | Advanced or Recurrent Solid TumorsAlbania
-
The University of Texas Health Science Center at...WithdrawnOvarian Cancer | Breast Cancer Stage IV | BRCA1 Mutation | BRCA2 Mutation
-
National Cancer Institute (NCI)RecruitingBreast Neoplasms | Colorectal NeoplasmsUnited States
-
Zhonglin HaoClovis Oncology, Inc.Active, not recruitingSmall Cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedBreast Cancer | Ovarian Cancer | Prostate CancerUnited States, Korea, Republic of, Italy, Australia, Spain
-
University of California, San FranciscoGlaxoSmithKlineRecruitingMetastatic Solid Tumor | BRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene MutationUnited States
-
National Cancer Institute (NCI)WithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Ovarian Serous Adenocarcinoma | Primary Peritoneal... and other conditions
-
Massachusetts General HospitalUniversity of Pennsylvania; Duke University; Sibley Memorial HospitalRecruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
Marc Dall'Era, MDNational Cancer Institute (NCI); Janssen, LPRecruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Prostate Carcinoma | RAD51C Gene Mutation | BRIP1 Gene Mutation | ATM Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | CDK12 Gene Mutation | CHEK1 Gene Mutation | DNA Damage Response Gene Mutation | DNA Repair Gene Mutation | FANCA Gene Mutation and other conditionsUnited States
-
PfizerAstellas Pharma IncActive, not recruitingProstate CancerUnited States, Finland, China, France, Spain, Hungary, United Kingdom, Korea, Republic of, Canada, Czechia, Taiwan, Belgium, Australia, Argentina, Japan, Germany, India, Turkey, Slovakia, Russian Federation, Bulgaria, Italy, Ukraine, ... and more
-
Vastra Gotaland RegionAdvanced Accelerator ApplicationsActive, not recruitingThymoma | Neuroendocrine Tumors | Mesothelioma | Clinical Trial, Phase ISweden
-
Ellipses PharmaCompletedOvarian CancerUnited States, United Kingdom, Hungary
-
SandozCompleted
-
Amy C. Sherman, MDMerck Sharp & Dohme LLCCompletedCytomegalovirus InfectionsUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | BRIP1 Gene Mutation | PALB2 Gene Mutation | ATM Gene Mutation | ATR Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | CHEK1 Gene Mutation | FANCA Gene... and other conditionsUnited States, Canada
-
University of Colorado, DenverCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...Merck Sharp & Dohme LLCRecruitingSCLC,Extensive StageItaly
-
Case Comprehensive Cancer CenterCompletedMetastatic or Unresectable MelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProgressive Disease | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Carcinoma | Endometrial Adenocarcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Platinum-Resistant Ovarian Carcinoma | High Grade Ovarian... and other conditionsUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Ovarian Epithelial TumorUnited States
-
John DiazMerck Sharp & Dohme LLC; Florida Department of HealthActive, not recruitingCervical Cancer | Cervical CarcinomaUnited States
-
GlaxoSmithKlineActive, not recruitingLung Cancer, Non-Small CellArgentina, France, Spain, Italy, Belgium, Korea, Republic of, United States, Mexico, Hungary, Sweden, Turkey, Ireland, Greece, Russian Federation, Germany, Netherlands, Bulgaria, Romania, Brazil, United Kingdom, Poland, Australia, C... and more
-
Cao WeijieRecruitingLetemovir for the Prevention of CMV Infection After Allo-HSCTChina
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingThe Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
-
Artios Pharma LtdRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States
-
AGO Research GmbHRecruitingEpithelial Ovarian CancerGermany
-
OHSU Knight Cancer InstituteEli Lilly and Company; GlaxoSmithKline; Oregon Health and Science UniversityActive, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Metastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | PALB2 Gene Mutation | ATM Gene MutationUnited States
-
AstraZenecaCompletedSolid TumoursDenmark, Belgium, United Kingdom, Netherlands
-
University of Turin, ItalyTesaro, Inc.Completed
-
National Cancer Institute (NCI)CompletedAstrocytoma | Ependymoma | Medulloblastoma | Pontine Glioma | PNETUnited States
-
University of WashingtonAstraZenecaTerminatedCastration-Resistant Prostate Carcinoma | Prostate AdenocarcinomaUnited States
-
University of Alabama at BirminghamTerminatedOvarian Cancer | Resistant BRCA Wild-Type Ovarian CancerUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingHematopoietic Stem Cell Transplantation | CMV InfectionChina
-
Samsung Medical CenterNot yet recruitingPremenopausal HR+/HER2- Metastatic Breast CancerKorea, Republic of